The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.

ABSTRACT: Metastatic castration-resistant prostate cancer (mCRPC) has a highly complex genomic landscape. With the recent development of novel treatments, accurate stratification strategies are needed. Here we present the whole-genome sequencing (WGS) analysis of fresh-frozen metastatic biopsies from 197 mCRPC patients. Using unsupervised clustering based on genomic features, we define eight distinct genomic clusters. We observe potentially clinically relevant genotypes, including microsatellite instability (MSI), homologous recombination deficiency (HRD) enriched with genomic deletions and BRCA2 aberrations, a tandem duplication genotype associated with CDK12^-/- and a chromothripsis-enriched subgroup. Our data suggests that stratification on WGS characteristics may improve identification

SUBMITTER: van Dessel LF 

PROVIDER: S-EPMC6868175 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature